Cargando…
Targeting BCL2-Proteins for the Treatment of Solid Tumours
Due to their central role in the regulation of apoptosis, the antiapoptotic BCL2-proteins are highly promising targets for the development of novel anticancer treatments. To this end, several strategies have been developed to inhibit BCL2, BCL-X(L), BCL-w, and MCL1. While early clinical trials in ha...
Autor principal: | Vogler, Meike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590949/ https://www.ncbi.nlm.nih.gov/pubmed/26556430 http://dx.doi.org/10.1155/2014/943648 |
Ejemplares similares
-
A direct comparison of selective BH3-mimetics reveals BCL-X(L), BCL-2 and MCL-1 as promising therapeutic targets in neuroblastoma
por: Bierbrauer, Annika, et al.
Publicado: (2020) -
Targeting the BCL-2-regulated apoptotic pathway for the treatment of solid cancers
por: Fairlie, W. Douglas, et al.
Publicado: (2021) -
Specific Targeting of Antiapoptotic Bcl-2 Proteins as a Radiosensitizing Approach in Solid Tumors
por: Sobol, Benjamin, et al.
Publicado: (2022) -
Role of Bcl-3 in solid tumors
por: Maldonado, Vilma, et al.
Publicado: (2011) -
Bcl-B: an “unknown” protein of the Bcl-2 family
por: Pervushin, N. V., et al.
Publicado: (2023)